Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02374398 · ClinicalTrials.gov registry record · Phase 4
Clinical Trial Comparing Tranexamic Acid (TXA) With Aquamantys Sealer in Total Knee Arthroplasty (TKA)
A Phase 4 study, sponsored by Eastern Maine Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 127
- Enrollment target
NCT02374398 is a Phase 4 study that has completed, run by Eastern Maine Medical Center. The registered enrollment target is 127 participants.
The verdict
NCT02374398, a Phase 4 study, has completed, sponsored by Eastern Maine Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 127 participants
- Enrollment target
Study Summary
The aim of the study is to determine if the use of iv TXA or Aquamantys system improve the postoperative hemoglobin and hematocrit after primary TKA and what is the effect of the simultaneous use of iv TXA and Aquamantys on the postoperative hemoglobin and hematocrit. The assumption is that the combination of iv TXA and Aquamantys system will enable an improvement in the postoperative hemoglobin and hematocrit equal or larger than the improvement generated by the use of Aquamantys system alone.
Interventions
- OTHER Control
- DRUG Tranexamic Acid
- DEVICE Aquamantys System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2011-03 |
| Est. Completion | 2014-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02374398
The ClinicalTrials.gov registry entry for NCT02374398 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Maine Medical Center, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT02374398 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02374398 about?
NCT02374398 is a clinical study titled "Clinical Trial Comparing Tranexamic Acid (TXA) With Aquamantys Sealer in Total Knee Arthroplasty (TKA)". The aim of the study is to determine if the use of iv TXA or Aquamantys system improve the postoperative hemoglobin and hematocrit after primary TKA and what is the effect of the simultaneous use of iv TXA and Aquamantys on the postoperative hemoglobin and hematocrit. The assumption is that the comb...
What is the current status of trial NCT02374398?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 127 participants. The study started on 2011-03. Estimated completion is 2014-11.
What interventions are being tested in trial NCT02374398?
The interventions under investigation include: Control (OTHER), Tranexamic Acid (DRUG), Aquamantys System (DEVICE).
Who is sponsoring clinical trial NCT02374398?
This trial is sponsored by Eastern Maine Medical Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.